OCT 09, 2019 6:00 AM PDT

Multilevel Interventions in Cancer Prevention and Control: A Community-Based Translational Research Framework to Address Prostate Cancer Disparities

Speaker

Abstract

Introduction: Despite the current declines in prostate cancer mortality, African Americans (AA) continue to experience a 60% higher incidence and are twice as likely to die in comparison to men of other racial and ethnic groups. A host of factors have been postulated to explain this inequity, including access to care, patient-centered communication, concordance of patient and physician race, level of prostate cancer knowledge, attitudes and perceptions of care, socioeconomic differences, differences in biological manifestation, type and aggressiveness of treatment, diet, genetics, and lifestyle and environmental factors.  There has been no consistent strategy employed to address prostate cancer disparities, not withstanding an increased effort to provide prostate cancer screening.  Screening and early detection are likely to assist; however, the scientific evidence to date has been insufficient to definitively conclude screening for prostate cancer reduces deaths.  While the uncertainty of the effectiveness of the screening modalities for prostate cancer persists, patients are encouraged to participate in the informed decision making (IDM) process with their healthcare provider to effectively incorporate their values and preferences. However, the extent of the patient-provider interaction in general has been found to be a barrier to securing adequate healthcare among racial and ethnic groups.  Mistrust, fear, discrimination, and racism have all been cited as factors of concern, for African American men in particular, when interfacing with the healthcare system. Four patient mediating outcomes of IDM include: 1) individual risk assessment, 2) consideration of values and beliefs, 3) knowledge of the risk and benefits of screening, and 4) consideration of age and lifespan issues (i.e., existing co-morbidities).  The extent of IDM in clinical settings is unclear.  The goal of this study was to establish effective delivery practice strategies with current recommendations for IDM for prostate cancer screening among African American men.  The use of Community Navigation and digital technology in community based settings allow for the innovativeness of this study.  We conducted a community-based, Randomized Controlled Trial, to assess the effectiveness of community based education as compared to clinical setting usual care in the delivery of the IDM process. The design of the study allowed for the evaluation of the effectiveness of utilizing the Community Navigators and an enhanced Patient Decision Aid in community-based venues to disseminate IDM to AA men. The two study arms were: 1) control (usual care group) and 2) experimental (enhanced patient decision aide and lay health advisory). The eligibility criteria for the participants included: 1) have not been diagnosed or treated for any type of cancer, 2) self-identify as AA, 3) able to understand English (ability to repeat back in their own words), 4) in the age range 40-70, and 5) working telephone number.  Study findings will be presented related to the primary outcome, IDM, measured through four domains: Knowledge, Decisional Conflict, Control Preferences, and Decisional Self-Efficacy. The findings of this study have informed effective community-based strategies with current recommendations for IDM.


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
OCT 09, 2019 6:00 AM PDT

Multilevel Interventions in Cancer Prevention and Control: A Community-Based Translational Research Framework to Address Prostate Cancer Disparities



Show Resources
Loading Comments...
Show Resources